Retatrutide vs Tirzepatide (Zepbound/Mounjaro): 2026 Comparison
Updated June 2026 · Reviewed by the MealFan editorial team
Key takeaways
- Reta (~24 to 28%) beats tirzepatide (~21%) on weight loss in trials.
- Tirzepatide is approved and available now; reta is not.
- Reta adds a glucagon pathway that may raise energy expenditure.
- If you need a drug today, tirzepatide wins by default.
Where should we send your plan?
- Your exact daily protein and calorie target
- Protein foods that fit your diet and allergies
- 50% off your first CookUnity box
Please enter a valid email.
Your plan and offer are emailed instantly. No spam, unsubscribe anytime, and we never sell your data.
'+
'
'+
'
'+
'
Your best protein picks ('+dietLabel+')
'+
'
CookUnity meals are 35 to 50g protein and filter by diet and allergens. New customers get 50% off the first order, then 10% off the next three boxes.
Claim the CookUnity offer →Independent recommendation. We may earn a commission, which never affects our picks.
'+
'
General guidance, not medical advice. Confirm targets with your prescribing clinician.
';
}
q('go').addEventListener('click',calc);
})();
The core difference: two pathways vs three
Tirzepatide hits two receptors (GLP-1 and GIP). Retatrutide adds a third, glucagon, which is thought to raise resting energy expenditure on top of appetite suppression. That extra lever is the leading theory for why reta's numbers run higher.
| Retatrutide | Tirzepatide | |
|---|---|---|
| Class | Triple agonist (GLP-1/GIP/glucagon) | Dual agonist (GLP-1/GIP) |
| Brands | None yet (investigational) | Zepbound, Mounjaro |
| Avg weight loss | ~24 to 28% (TRIUMPH-1, 80 wk) | ~20.9% (SURMOUNT-1, 72 wk) |
| FDA status | Not approved; filing expected end 2026 | Approved and available |
| Available now? | No | Yes |
Which should you care about?
If you're choosing a treatment today, the honest answer is tirzepatide, it's approved, covered by some plans, and has years of real-world use. Retatrutide matters if you're planning ahead or following the science. Either way, the nutrition playbook is identical: protect muscle with protein as appetite falls.
On a GLP-1 drug now or soon? Pre-portioned, high-protein meal delivery makes the protein target easy.
What to Eat on Retatrutide or Tirzepatide: High-Protein Meals
Whether you’re on retatrutide or tirzepatide, the nutrition playbook is the same: protect muscle with protein while appetite drops. CookUnity’s high-protein line runs 25-30g+ protein per serving (steak and salmon dishes often 40g+), plans from ~$14/meal. Verified picks:
| CookUnity meal | Protein | Calories | Carbs |
|---|---|---|---|
| Chicken & Quinoa Power Bowl | 53g | 590 | 34g |
| Chipotle Lime Salmon | 40g | 480 | 21g |
| Curried Grilled Chicken with Spiced Cauliflower | 45g | 450 | 46g |
| Chipotle BBQ Chicken Bowl | 37g | 660 | 59g |
On either medication 30g+ protein per meal is the target; the Power Bowl leads at 53g. Every CookUnity meal shows exact protein, carbs, fat and calories, and you can filter the menu by “High Protein.”
50% off your first box + 10% off boxes 2 & 3
High protein whichever you take. Chef-made, high-protein, delivered fresh — discount applies automatically through our link.
Get 50% Off CookUnity →MealFan may earn a commission if you order through this link, at no extra cost to you. General nutrition info, not medical advice.
FAQ
Is retatrutide stronger than tirzepatide?
In the trial data, yes, retatrutide averaged roughly 24 to 28% weight loss vs tirzepatide's ~21%. But these are separate trials, not head-to-head, and retatrutide is not approved yet.
Can I switch from Zepbound to retatrutide?
Not currently, retatrutide is investigational and not available by prescription. Realistic availability is late 2027 to 2028.
Do they have the same side effects?
Both are mostly gastrointestinal (nausea, etc.) during dose escalation. Retatrutide's glucagon component can additionally raise heart rate slightly.
Why the third pathway matters
Both drugs quiet appetite through GLP-1 and GIP. Retatrutide adds glucagon-receptor agonism, and that single addition changes the math. Glucagon at these doses is thought to nudge resting energy expenditure upward and push the liver to burn stored fat, so reta works the calories-out side of the equation as well as calories-in. Tirzepatide leans almost entirely on eating less. That is the leading explanation for why reta's trial numbers run several points higher despite a similar tolerability profile.
Side effects, compared
Day to day, the two feel similar: gastrointestinal complaints that cluster after each dose increase and settle at a stable dose. The one structural difference is reta's glucagon component, which can modestly raise heart rate and shift glucose handling, so its trials titrate slowly and monitor closely. Tirzepatide has years of real-world safety data behind it; reta's safety record is still being built in trials.
| Retatrutide | Tirzepatide | |
|---|---|---|
| Main side effects | GI (nausea, diarrhea, vomiting, constipation) | GI (nausea, diarrhea, vomiting, constipation) |
| Extra consideration | Glucagon can raise heart rate slightly | Well-characterized, large real-world dataset |
| Tolerability lever | Slow dose escalation | Slow dose escalation |
Cost and access (when reta arrives)
Tirzepatide is here now, with some insurance coverage and manufacturer savings programs, though out-of-pocket cost without coverage remains high. Retatrutide has no price yet because it has no approval yet; launch pricing typically lands in the same ballpark as existing branded GLP-1 drugs, and coverage takes time to build after launch. If cost and availability matter today, tirzepatide is the practical choice.
Who each is best for
Choose what's available (tirzepatide) if you want to start treatment now, value a long safety track record, or need insurance coverage. Watch retatrutide if you're following the science, haven't responded enough to current drugs, or are planning a few years out. Either way the eating plan is identical: hit your protein target so the weight you lose is fat, not muscle.
The Retatrutide 2026 series
The nutrition side most drug guides skip
We are a food site, so here is what the drug-only sites leave out: retatrutide and tirzepatide (Zepbound/Mounjaro) works by shrinking appetite, and that creates a real nutritional risk. When you eat far less, you do not just lose fat, you can lose muscle and fall short on protein, fiber, and key vitamins and minerals. The fix is not eating more; it is making every bite count.
The four risks to manage (and the food fix)
| Nutrition risk | Why it happens | The food fix |
|---|---|---|
| Muscle & protein loss | Rapid weight loss plus too little protein, up to a third of lost weight can be lean muscle. | 1.2 to 1.6 g protein per kg body weight daily; anchor every meal and snack with protein. |
| Low micronutrients | Eating far less total food shrinks intake of iron, B12, calcium, vitamin D, potassium and magnesium. | Nutrient-dense picks: eggs, salmon/sardines, Greek yogurt, leafy greens, beans, nuts and seeds, fortified foods. |
| Constipation | Slowed digestion plus less food and fiber. | Fiber-rich vegetables and fruit you can tolerate; steady fluids; move daily. |
| Dehydration & low energy | Reduced intake and GI fluid losses during dose changes. | Sip fluids and electrolytes through the day; never skip food entirely. |
What to actually eat on retatrutide and tirzepatide (Zepbound/Mounjaro)
- Protein at every meal and snack: eggs, chicken, fish, Greek yogurt, cottage cheese, tofu, beans, or a protein shake. When you can only finish a few bites, make them protein.
- Nutrient-dense, smaller-volume foods: salmon and sardines (omega-3, vitamin D, B12), eggs, dairy, leafy greens, beans and lentils, nuts and seeds, berries.
- Easy formats for nausea days: protein smoothies (protein powder + fruit + spinach), broth-based soups, yogurt.
- Hydration and fiber: water and electrolytes through the day, plus tolerable high-fiber vegetables and fruit to keep things moving.
If your appetite is so low that you are eating very little, a daily multivitamin can backstop the gaps, ask your prescribing clinician. The goal across the board: protect muscle and stay nourished while the medication does its job.
The simplest way to hit these numbers while your appetite is unpredictable is pre-portioned, macro-labeled meal delivery built for exactly this.
See our tested GLP-1 meal delivery picks →
Or browse Best High-Protein Meal Delivery
Weight loss by trial and dose (the exact figures)
Our headline range is intentionally conservative; here are the specific trial readouts so you can see where the numbers come from.
| Drug / dose | Trial | Duration | Weight loss |
|---|---|---|---|
| Retatrutide 12 mg | Phase 2 (NEJM 2023) | 48 weeks | 24.2% |
| Retatrutide 12 mg | TRIUMPH-1 (Phase 3) | 80 weeks | ~24 to 28% (45.3% lost ≥30%) |
| Retatrutide 12 mg | TRIUMPH-4 (obesity + knee OA) | up to 80 weeks | up to 28.7% |
| Tirzepatide 15 mg | SURMOUNT-1 | 72 weeks | 20.9% |
There is no head-to-head trial. An indirect network meta-analysis of the published trials estimated greater average weight loss for retatrutide (about 23.8%) than tirzepatide (about 16.8%), consistent with the direct trial readouts above, but indirect comparisons carry more uncertainty than a head-to-head study would.
Sources & references
- Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 Trial. New England Journal of Medicine (2023).
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (2022).
- Eli Lilly. Retatrutide delivered powerful weight loss in pivotal Phase 3 obesity trial (TRIUMPH-1). Lilly press release (2026).
- Retatrutide, overview, mechanism, trial history. Wikipedia.
- Tirzepatide, overview. Wikipedia.
Related reading
Figures reflect Eli Lilly topline disclosures and peer-reviewed trial publications as of June 25, 2026. Retatrutide remains investigational; we will update on FDA action. Not medical advice.
Find your meal kit in 2 minutes
Answer 5 quick questions. We'll match you to the top 3 from 24 services we track.
Popular comparisons
Compare across all our rankings
- Best Meal Delivery Services of 2026: our master ranking of the top 10 services in the United States.
- Best High Protein Meal Delivery: ranked for athletes, weight management, and GLP 1 friendly meals.
- Best Diabetic Meal Delivery: ranked for Type 2 diabetes, pre diabetes, and insulin support.
- Best GLP 1 Meal Delivery: ranked for Ozempic, Wegovy, Mounjaro, and Zepbound users.
